Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
11.45
+0.15 (1.33%)
Aug 14, 2026, 4:00 PM EDT - Market closed
Artiva Biotherapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $559.79 million as of August 14, 2026. Its market cap has increased by 758.36% in one year.
Market Cap
559.79M
Enterprise Value
220.25M
1-Year Change
758.36%
Ranking
Category
Stock Price
$11.45
ChartMarket Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has increased from $176.76M to $559.79M, an increase of 216.70%. That is a compound annual growth rate of 74.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 559.79M | 431.63% |
| Dec 31, 2025 | 105.30M | -56.99% |
| Dec 31, 2024 | 244.84M | 38.52% |
| Jul 19, 2024 | 176.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CorMedix | 587.70M |
| Arvinas | 586.51M |
| Autolus Therapeutics | 572.21M |
| Altimmune | 571.88M |
| Prelude Therapeutics | 571.62M |
| ARS Pharmaceuticals | 561.88M |
| Ovid Therapeutics | 552.69M |
| Prime Medicine | 549.72M |